Yajima, Satoshi
Suzuki, Takashi
Oshima, Yoko
Shiratori, Fumiaki
Funahashi, Kimihiko
Kawai, Shinichi
Nanki, Toshihiro
Muraoka, Sei
Urita, Yoshihisa
Saida, Yoshihisa
Okazumi, Shinichi
Kitagawa, Yuko
Hirata, Yuki
Hasegawa, Hirotoshi
Okabayashi, Koji
Murakami, Masahiko
Yamashita, Takeshi
Kato, Rei
Matsubara, Hisahiro
Murakami, Kentaro
Nakajima, Yasuaki
Sugita, Hironobu
Klammer, Martin
Shimada, Hideaki http://orcid.org/0000-0002-1990-8217
Funding for this research was provided by:
JSPS KAKENHI (JP16K10520)
Article History
Received: 31 August 2020
Accepted: 20 October 2020
First Online: 18 November 2020
Disclosure
: All sites received research funding from Roche Diagnostics K.K. Hironobu Sugita is an employee of Roche Diagnostics K.K., and Martin Klammer is an employee of Roche Diagnostics GmbH. Sei Muraoka has received consultant fees from Asahikasei Pharma Corporation, and speakers bureau fees from Ono Pharmaceutical Co., Ltd, Eisai Co., Ltd, Asahikasei Pharma Corporation, and Astellas Pharma Inc. Yuko Kitagawa has relevant financial activities outside the submitted work: Taiho Pharmaceutical Co., Ltd; Chugai Pharmaceutical Co., Ltd; Yakult Honsha Co., Ltd; Daiichi Sankyo Company, Ltd; Merck Serono Co., Ltd; Asahikasei Co., Ltd; EA Pharma Co., Ltd; Otsuka Pharmaceutical Co., Ltd; Takeda Pharmaceutical Co., Ltd; Otsuka Pharmaceutical Factory Inc.; Shionogi & Co., Ltd; Kaken Pharmaceutical Co., Ltd; Kowa Pharmaceutical Co., Ltd; Astellas Pharma Inc.; Medicon Inc.; Dainippon Sumitomo Pharma Co., Ltd; Taisho Toyama Pharmaceutical Co., Ltd; Kyouwa Hakkou Kirin Co., Ltd; Pfizer Japan Inc.; Ono Pharmaceutical Co., Ltd; Nihon Pharmaceutical Co., Ltd; Japan Blood Products Organization; Medtronic Japan Co., Ltd; and Sanofi K.K. Yuko Kitagawa has also received grants from Eisai Co., Ltd; Tsumura & Co.; KCI Licensing, Inc.; Abbott Japan Co., Ltd; Fujifilm Toyama Chemical Co., Ltd; and Medicon Inc. Hideaki Shimada has received lecture fees from Ono Pharmaceuticals Ltd and Taiho Pharmaceuticals Ltd. Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Fumiaki Shiratori, Kimihiko Funahashi, Shinichi Kawai, Toshihiro Nanki, Yoshihisa Urita, Yoshihisa Saida, Shinichi Okazumi, Yuki Hirata, Hirotoshi Hasegawa, Koji Okabayashi, Masahiko Murakami, Takeshi Yamashita, Rei Kato, Hisahiro Matsubara, Kentaro Murakami, and Yasuaki Nakajima have no conflicts of interest to declare.